Abstract:Purpose: Breast cancer is the leading cause of cancer death worldwide in women. The molecular mechanism for human breast cancer is unknown. Gene microarray has been widely used in breast cancer research to identify clinically relevant molecular subtypes as well as to predict prognosis survival. So far, the valuable multigene signatures in clinical practice are unclear, and the biological importance of individual genes is difficult to detect, as the described signatures virtually do not overlap. Early prognosis of this disease, breast invasive ductal carcinoma (IDC) and breast ductal carcinoma in situ (DCIS), is vital in breast surgery.Methods: Thus, this study reports gene expression profiling in large breast cancer cohorts from Gene Expression Omnibus, including GSE29044 (N=138) and GSE10780 (N=185) test series and four independent validation series GSE21653 (N=266), GSE20685 (N=327), GSE26971 (N=276), and GSE12776 (N=204). Significantly differentially expressed genes in human breast IDC and breast DCIS were detected by transcriptome microarray analysis.Results: We created a set of three genes (MAMDC2, TSHZ2, and CLDN11) that were significantly correlated with disease-free survival of breast cancer patients using a univariate Cox regression model (significance level P<0.01) in a meta-analysis. Based on the risk score of the three genes, the test series patients could be separated into low-risk and high-risk groups with significantly different survival times. This signature was validated in the other three cohorts. The prognostic value of this three-gene signature was confirmed in the internal validation series and another four independent breast cancer data sets. The prognostic impact of one of the three genes, CLDN11, was confirmed by immunohistochemistry. CLDN11 was significantly overexpressed in human breast IDC as compared with normal breast tissues and breast DCIS.Conclusion: Using novel gene expression profiling together with a meta-analysis validation approach, we have identified a three-gene signature with independent prognostic impact. Furthermore, CLDN11 may offer a biomarker to predict prognosis as well as a new target for prognostic and therapeutic intervention for human breast IDC.

Mining TCGA Database for Genes with Prognostic Value in Breast Cancer

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Telomere-Associated Gene Signatures Correlate with Prognosis, Tumor Microenvironment, and Chemosensitivity in Breast Cancer.

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

A Novel Coiled-Coil Domain Containing-Related Gene Signature for Predicting Prognosis and Treatment Effect of Breast Cancer.

Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer

Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer

Mining TCGA database for genes of prognostic value in glioblastoma microenvironment

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Abstract 1671: Characterization of a Gene Signature Predictive of Cancer Patient Survival Prognosis and Chemo-Response

Mining TCGA Database for Genes of Prognostic Value in Gastric Cancer Microenvironment

Using the TCGA Database to Predict and Analyze Tumor Microenvironment Genes Related to Poor Prognosis of Colon Cancer

Combining Data from TCGA, GEO Database, and RT-qPCR Validation to Identify Gene Prognostic Marker in Lung Cancer

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Tumor Microenvironment-Related Multigene Prognostic Prediction Model for Breast Cancer

Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database

Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment

Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment

Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers

Multivariate Analysis of Prognostic Factors for Breast Cancer